Sleep Study Systems

1st Line Medical Inc. is a US-based sleep medicine and obstructive sleep apnea (OSA) solutions provider headquartered in Holderness, NH. The company manufactures and distributes FDA-cleared home sleep testing systems and oral appliance therapy devices designed to simplify and accelerate OSA diagnosis and treatment. Primary product lines include the SleepImage NightOwl home sleep testing system (wearable ring-based diagnostic) and SomnoGuard custom oral appliances (AP2 and SPX models), which represent alternatives to CPAP therapy for OSA and snoring management. The company also distributes Airlift hyoid suspension information for surgical candidates. 1st Line Medical serves airway specialist physicians, sleep medicine practitioners, and patients across the United States through a direct-to-provider and patient-facing model. The organization emphasizes rapid diagnostic pathways and treatment initiation, positioning products as time- and cost-effective solutions compared to traditional multi-month OSA diagnostic and therapeutic workflows. Products are FDA cleared for home use and carry regulatory approval for both diagnostic and therapeutic applications. The company provides physician training through the SomnoGuard Academy, practice support tools, prescription programs, and dedicated customer service (9 AM–5 PM EST, Monday–Friday). Distribution includes direct reordering of devices and supplies through their web portal.

Anriwell is a medical-grade home health monitoring platform specializing in connected devices and ecosystem solutions for elderly care and family wellness. The company manufactures FDA-cleared and MDR-certified vital sign monitoring devices including blood pressure monitors, glucose meters, pulse oximeters, infrared thermometers, and intelligent sleep monitors. All devices integrate with the Anriwell App, which centralizes health data tracking, family sharing, and remote monitoring capabilities. Beyond hardware, Anriwell Home provides smart home safety features (fall detection, water/gas sensors) designed to enable independent living for seniors. The ecosystem is positioned for multi-generational caregiving, enabling remote family members to monitor loved ones' health trends and receive alerts for early intervention.

Jali Medical is a leading U.S. distributor of neuromodulation devices and wearable neurotechnologies, headquartered in Framingham, Massachusetts. Founded in 1991 with over 30 years of experience, the company specializes in non-invasive brain stimulation systems for neuroscience research and clinical applications. Jali Medical distributes FDA-cleared Transcranial Magnetic Stimulation (TMS) therapy systems for treating Major Depressive Disorder, along with advanced electroencephalography (EEG) systems, transcranial direct current stimulation (tDCS/tACS) devices, electromyography (EMG) systems, and neuronavigation equipment. The company serves academic institutions, research centers, hospitals, and clinicians nationwide, providing precision-engineered neurotechnology coupled with comprehensive scientific support. Jali Medical offers flexible leasing options for TMS therapy systems and in-person product demonstrations to facilitate clinical adoption and research innovation in neurophysiology and behavioral health applications.

Med-Dyne is a leading manufacturer of pediatric and adult monitoring solutions based in Louisville, Kentucky. Founded in 1993, the company brings over 30 years of expertise in biofeedback and monitoring technology. Med-Dyne specializes in medical monitoring accessories for ECG, EEG, sleep testing, and infant apnea monitoring applications. The company manufactures a comprehensive range of disposable and reusable electrodes, pre-wired leadwires, cables, and specialized testing supplies with a focus on sensitive skin compatibility. Med-Dyne's patented hydrogel adhesive technology is designed specifically for pediatric patients with delicate skin, offering a firm yet gentle bond with reduced impedance for superior signal quality. The company provides full custom design and packaging capabilities, maintains inventory in stock for rapid fulfillment, and offers same-day shipping. With a central US location and dedicated customer service, Med-Dyne serves healthcare facilities requiring reliable cardiac monitoring, sleep study, and EEG supplies.

Nox Medical is a specialized sleep diagnostics company founded in 2006 and headquartered in Reykjavík, Iceland. The company designs and manufactures portable polysomnography (PSG) systems and home sleep testing (HST) devices for sleep medicine practitioners globally. Nox Medical's flagship products include the Nox A1 PSG System—a full portable polysomnography platform for in-lab and ambulatory sleep studies—and the Nox T3s HST Device, a next-generation home sleep testing system. Both platforms incorporate AI-assisted scoring and data management capabilities to enhance diagnostic accuracy and simplify workflow. The company's technologies are deployed across 50 countries by sleep medicine centers, hospitals, and research institutions to diagnose sleep disorders including obstructive sleep apnea. Nox Medical emphasizes user-friendly design, patient comfort, and scalable solutions that expand access to sleep diagnostics across diverse patient populations.

Löwenstein Medical is a leading manufacturer of ventilation and respiratory therapy equipment serving the diagnostics, hospital, and homecare segments. For nearly 40 years, the company has specialized in innovative medical devices for neonatal, intensive care, sleep apnea therapy, and sleep diagnostics applications. The product portfolio includes ventilators designed to mimic natural breathing patterns, oxygen delivery systems, CPAP devices, and comprehensive sleep study solutions. Löwenstein operates as a market leader in sleep diagnostics in Germany and provides ergonomic, user-centric medical technology across acute care and chronic respiratory management. The company emphasizes gentle, effective ventilation principles originating from neonatology expertise and offers extensive technical support, maintenance, and professional training through the Löwenstein Academy.

EnsoData is a healthcare technology company specializing in AI-powered software solutions for sleep medicine diagnostics and management. Founded in 2015 and based in Madison, Wisconsin, the company develops FDA-cleared cloud-based platforms that automate sleep study scoring and analysis using machine learning to process polysomnography (PSG) and home sleep apnea test (HSAT) waveforms. EnsoData's integrated ecosystem—comprising EnsoHST (multi-night home sleep testing device), EnsoSleep (AI-assisted scoring and analysis), EnsoHub (centralized study management platform), and Therapy Track (long-term therapy monitoring)—enables sleep clinics to streamline workflows, reduce diagnostic turnaround times, and improve clinical accuracy. The platform has processed over 2.8 million studies and impacted more than 2.5 million patients. EnsoData serves 500+ sleep clinics globally and achieves 97% patient success rates with >92% sensitivity for obstructive sleep apnea detection. The company's solutions address scalability challenges in sleep medicine and expand access to diagnosis for the estimated 425 million patients worldwide with undiagnosed sleep disorders.

Onera Health is a MedTech and Digital Health company based in Eindhoven, Netherlands, specializing in innovative wire-free polysomnography (PSG) solutions for sleep diagnostics and monitoring. The company's flagship product, the Onera Sleep Test System (STS), is a patch-based sensor system that captures comprehensive PSG data on cardiovascular, respiratory, and brain functions with a user-friendly, self-applicable design. Unlike traditional clinic-based sleep studies, Onera's solution enables patients to conduct high-quality clinical-grade PSG testing at home with minimal sleep disturbance. The company offers a PSG-as-a-Service model combining hardware with a cloud-based digital health platform, enabling clinicians to order, conduct, and analyze sleep studies remotely without upfront capital investment. The platform handles complete workflows from patient self-application to automated data processing, analysis, and EDF file reporting compatible with standard sleep analysis software. This approach addresses sleep disorders including sleep apnea, insomnia, and narcolepsy while reducing costs and improving patient access to diagnostic testing.

Bittium Corporation is a Finnish high-tech engineering company specializing in secure communications, connectivity solutions, and medical technologies. Founded in 1985 and based in Oulu, Bittium operates across three primary business areas: Defence & Security (tactical and secure communications systems), Medical (biosignal monitoring solutions for cardiology and neurophysiology), and Engineering Services (high-end product development in secure connectivity and embedded systems). The company leverages over 40 years of advanced radio communication expertise to deliver customized solutions for complex, mission-critical environments. In the medical space, Bittium develops innovative biosignal measurement and monitoring technologies, including home sleep apnea testing solutions and cardiology/neurophysiology diagnostic systems. With approximately 500 employees across Finland, Germany, and the USA, and listed on Nasdaq Helsinki, Bittium reported net sales of €85.2 million in 2024. The company's solutions emphasize security, reliability, and data integrity for healthcare providers and defence/public safety organizations.

S.L.P. Inc. (doing business as SleepSense) is a global manufacturer of sleep diagnostic sensors established in 1993. The company specializes in designing and manufacturing high-quality, patient-comfortable sensors for sleep studies and polysomnography. SleepSense® product lines include snore sensors, thermal airflow sensors, pressure sensors, respiratory effort sensors, limb movement sensors, body position sensors, pulse oximetry (SpO2) sensors, and pressure cannulas. The company also offers the ThermoCan™ System for simultaneous monitoring of oral/nasal thermal airflow and nasal pressure. Product line includes both disposable and reusable sensor options, featuring technologies such as PVDF, piezo, and inductive designs. SleepSense sensors are designed for optimal signal quality with minimal artifact, ease of application, and patient comfort. The company maintains a comprehensive product catalog and offers cleaning guidelines, warranty information, and sensor science documentation. SleepSense products serve sleep laboratories, hospital sleep centers, and diagnostic facilities globally. The company operates US operations from Elgin, Illinois and maintains international operations through S.L.P. Ltd in Tel Aviv, Israel. Quality systems and manufacturing standards are documented on the company website.

AIOMEGA LLC is a Tyler, Texas-based medical device company founded by Dr. R.V. Ghuge, a board-certified sleep medicine physician and president of Sleep Medicine Institute of Texas. The company develops patented oral airway devices for the treatment of obstructive sleep apnea (OSA) and snoring in both adult and pediatric populations. AIOMEGA's flagship product line includes the AIO Breathe (FDA-cleared for mild-to-moderate OSA in adults and children), AIO Breathe MB, AIO Swift, AIO Grit, AIO Brut, and AIO Revive. These devices are positioned as non-invasive alternatives to CPAP therapy, marketed for both medical and sports applications. The company emphasizes unprecedented airflow improvement through their proprietary technology. Products are available through The PAP Store e-commerce platform. AIOMEGA holds FDA clearance for treatment of OSA and snoring. The company serves dentists, physicians, athletes, coaches, trainers, and employees through dedicated portals, indicating multi-stakeholder market positioning. Manufacturing and product details beyond FDA-cleared status are not disclosed on the public website.

Neurotronics is a medical device manufacturer specializing in sleep diagnostic systems and related equipment. The company develops and markets a comprehensive portfolio of sleep study products, including the NomadAir portable diagnostic device, Polysmith Sleep Diagnostic Software, proprietary Neurotronics Sensors, Live View Panel monitoring technology, and the Sphinx PMU710 polysomnography unit. These products are designed for sleep medicine clinicians and diagnostic laboratories conducting overnight and home-based sleep studies. Neurotronics emphasizes robust engineering, user-friendly design, and superior customer support. The company distributes products in the United States through Nihon Kohden America and internationally via Nihon Kohden's distributor network. Neurotronics maintains a quality system focused on continuous improvement and maintains a customer support scorecard to track service delivery. The company has established expertise in medical device product development with particular depth in sleep diagnostics.

Carrier Medical, LLC is a leading distributor of medical equipment and solutions serving VA and DOD hospitals nationwide. The company specializes in providing high-quality medical devices across multiple specialties including neurology, sleep diagnostics, physical medicine and rehabilitation, respiratory care, and CPAP comfort products. Product lines include CPAP mask liners and headgear comfort covers made from bamboo organic fabric (Cloud brand); mobility and assistive devices such as rollators, knee walkers, transport chairs, and canes (PerfectFit, Phantom, Nova brands); and sleep diagnostic consumables including EEG electrodes and complete sensor kits (Dymedix brand). The company operates an e-commerce platform offering direct purchasing with nationwide fast shipping. Carrier Medical serves both institutional and individual customers, with documented experience supplying hospital inventory for multi-year partnerships. Products emphasize comfort, durability, and quality construction with features such as machine-washable liners and heavy-duty weight capacities. The company maintains customer support infrastructure and satisfaction guarantees.

SOMNOmedics GmbH is a German medical technology manufacturer specializing in portable, wearable diagnostic systems for sleep medicine, cardiology, and neurology. Founded approximately 20 years ago, the company develops and manufactures a comprehensive portfolio of sleep diagnostic equipment including polysomnography (PSG) systems, portable polygraphic devices, actigraphy monitors, and home sleep apnea testing solutions. Product lines include the SOMNO HD and SOMNO HD eco for in-lab and ambulatory polysomnography; SOMNOtouch RESP and SOMNOtouch RESP eco for respiratory polygraphic recordings; SOMNOwatch eco and SOMNOwatch plus for actigraphy and research applications; and specialized devices such as the O-Two Fellow for pulse oximetry and the NARCOguide for anesthesia depth monitoring. In cardiology, SOMNOmedics offers the SOMNOtouch NIBP for non-invasive continuous blood pressure measurement via pulse transit time (PTT) and the ABPMpro for oscillometric ambulatory blood pressure monitoring. The company also provides long-term EEG systems and insomnia diagnostics software. All devices are designed as modular, wearable systems with wireless connectivity options. SOMNOmedics emphasizes high-quality German manufacturing, invests 20% of revenue in R&D, and holds multiple patents in continuous blood pressure monitoring and wireless sensor technology. Products carry CE marking (referenced as 0297) indicating compliance with European Medical Device Regulation. The company provides 24/7 complimentary customer support and regular free software updates.

Neurovirtual USA, Inc. is a global manufacturer of neurology and sleep medicine diagnostic equipment. The company specializes in advanced diagnostic systems for sleep medicine, neurology, and related clinical applications. Their product portfolio includes sleep study systems, EEG/EMG equipment, and ambulatory EEG monitoring solutions. Neurovirtual positions itself as a fast-growing provider committed to offering advanced diagnostic equipment at competitive pricing without compromising quality. The company serves healthcare facilities requiring neurology and sleep medicine diagnostic capabilities, with demonstrated presence at major medical conferences including SBNC (Sleep and Brain Disorders Conference) and epilepsy educational events. Manufacturing and distribution operate on a global scale. While specific regulatory certifications are not explicitly detailed in available marketing materials, the company's participation in professional medical conferences and focus on clinical diagnostics suggests compliance with relevant medical device standards.

Dormotech Medical Inc. is a medical device manufacturer specializing in wireless sleep diagnostic systems. The company develops and markets DormoVision X™, a comprehensive polysomnography (PSG) platform designed for both home sleep apnea testing (HSAT) and in-laboratory sleep studies. The system captures 29 direct physiological channels and 9 derived channels, including EEG, EOG, chin EMG, ECG, SpO₂, nasal/oral airflow, respiratory effort, snoring/breathing sounds, body and head position, and modular ExG measurements for leg, limb, and chest activity. DormoVision X™ is cloud-based and wireless, eliminating traditional wired equipment complexity while delivering in-lab quality diagnostic data. The platform supports all three sleep study types (Type 1, 2, and 3) and accommodates pediatric patients age 6 and older with patient-friendly wireless sensors and soft materials. Clinical validation demonstrates 97% equivalence with traditional in-lab PSG. The system enables unlimited multi-night testing to capture night-to-night variability and includes automated AI-driven analysis for sleep staging, arousal detection, and event classification. Dormotech targets sleep medicine clinics, hospitals, and diagnostic centers seeking to expand capacity without adding physical lab beds or overhead. The usage-based, scalable cloud model supports expansion across multiple locations. The company is recognized for innovation in sleep medicine and maintains an advisory board of leading sleep medicine physicians and researchers.

Dymedix Diagnostics is a Minnesota-based manufacturer of diagnostic sensors for clinical sleep medicine, operating for over 15 years. The company specializes in designing and manufacturing disposable and reusable sleep study sensors using proprietary PVDF (polyvinylidene fluoride) technology. Their product portfolio includes airflow sensors, snore detection sensors, respiratory effort sensors, and surface electrodes used in polysomnography (sleep testing). Key product lines include TriplePlay™ Airflow Sensors, PerfectFit™ Effort Sensors, and AccuSnore™ Snore Sensors. The PVDF-based design provides sensitivity to movement, pressure, strain, temperature, and vibration, enabling accurate waveform capture in sleep diagnostic applications. Dymedix serves sleep medicine laboratories, pulmonology centers, and sleep disorders clinics. The company maintains both disposable and reusable sensor options to meet varied clinical and operational requirements. Products are designed with input from technologists, physicians, and patients to optimize clinical utility and patient comfort.

DEYMED Diagnostic is a Czech-headquartered manufacturer of advanced neurophysiology and psychiatry diagnostic and treatment systems, operating since 1997. The company designs and manufactures EEG (electroencephalography), EMG (electromyography), PSG (polysomnography), TMS (transcranial magnetic stimulation), and biofeedback systems for clinical and research applications. Products are distributed across 60+ countries with over 12,000 units installed globally. All devices are engineered to ISO 13485 and FDA 21 CFR Part 820 quality management standards, comply with EN 60601 safety requirements, and carry CE marking. The company operates a multi-functional product portfolio: TruScan EEG for portable, clinical, and long-term monitoring; TruTrace EMG for nerve conduction studies, electromyography, and autonomic nervous system assessment (battery-powered, configurable as cart or portable); SomniPro PSG for sleep studies; DuoMAG rTMS/TMS systems (monophasic and biphasic variants) for clinical and research brain stimulation; and BrainFeedback/neurofeedback systems for neurotraining. The company emphasizes close collaboration with clinical specialists during development, strict quality testing, and comprehensive technical support including remote assistance tools. Service and support are available Monday–Friday, 8:00–17:00 CET, with both quick and unattended remote support applications provided. Systems are designed to run on Windows 7 through Windows 10 on standard desktop or laptop hardware.

hinlab Inc. is a Palo Alto-based healthtech company developing FDA-cleared wearable monitoring cuffs for clinical-grade vital signs measurement in hospital, home, and clinical trial settings. The company manufactures two primary product lines: hinscope (adult cuff) and Gabi (pediatric cuff), both wireless, waterproof devices that capture blood pressure, pulse rate, and SpO₂ automatically without patient intervention. Devices integrate with cloud-based platforms for real-time data synchronization, alert generation, and clinician dashboards on mobile devices and central monitoring stations. hinlab targets emergency departments, post-surgical recovery units, remote patient monitoring programs, sleep diagnostics (pediatric and adult), and decentralized clinical research. The Gabi platform, acquired in August 2025, enables home-based sleep study analysis for children aged 28 days to 12 years. Both devices are FDA-cleared medical devices, clinically validated, and designed to detect respiratory and physiological deterioration early (addressing the clinical gap of 90% undetected respiratory crashes on general wards). hinlab is part of Stanford's StartX accelerator and holds ISO certification. Products are available by prescription or for healthcare professional purchase only and are HSA/FSA eligible. The company serves major hospital systems and research institutions including Cleveland Clinic, UCSF, and others.

Medeia Inc is a manufacturer and distributor of neurodiagnostic and cardiovascular physiological monitoring systems. Founded in 1992, the company specializes in state-of-the-art biometric hardware and software for autonomic nervous system assessment, vascular analysis, EEG/EEG-derived diagnostics, and sleep studies. Medeia's product portfolio serves neurologists, cardiologists, primary care physicians, and research institutions with comprehensive tools for objective physiological measurement, including autonomic function testing (ANS), pulse wave velocity analysis, peripheral neuropathy assessment, and neuroencephalography. The VitalScan product line addresses autonomic and vascular diagnostics; BrainView systems provide EEG and cognitive assessment; NeuroTrace offers ambulatory wireless EEG; SleepStudy delivers polysomnography; and CardioView supplies mobile cardiac telemetry. Products are designed for clinical workflow efficiency and are distributed internationally to healthcare providers and research facilities.

CleveMed is a Cleveland-based medical device manufacturer specializing in portable home sleep apnea testing (HSAT) solutions. Founded in 1990, the company offers a comprehensive sleep diagnostics platform including the SleepView® Monitor, a portable polysomnography device for in-home sleep apnea screening; SleepView Web Portal, a cloud-based data management and reporting system; and SleepView™ Direct, a mail-order fulfillment service that streamlines equipment distribution and result delivery directly to patients. CleveMed serves primary care practices, sleep laboratories, and corporate wellness programs. The company holds FDA clearance, ISO 13485 and ISO 27001 certifications, and AACHC accreditation. With approximately $6.3 million in annual revenue, CleveMed focuses on expanding access to sleep medicine diagnostics while maintaining clinical quality and after-sales service excellence.

Snap Diagnostics is a clinical laboratory and diagnostic service provider specializing in home sleep apnea testing (HST). The company operates a mail-based, direct-to-patient testing model where patients receive portable sleep study kits at home, conduct testing in their natural sleep environment, and return devices for analysis. The proprietary system measures five to six essential channels of sleep data: airflow, respiratory effort, oximetry, heart rate, body position, and acoustic signatures (snoring). Post-study analysis combines automated software processing with manual review by certified sleep technicians to identify obstructive and central apnea events, irregular respiratory patterns, and calculate clinical indices (AHI, RDI, REI). The company supports multi-night testing capability and maintains a HIPAA-compliant online portal for order management, patient registration, and results distribution. Snap accepts most major insurance plans (excluding Medicaid as primary) and offers 24/7 patient support. The company has operated for 30 years and serves a national patient base through physician referral and direct provider ordering via online portal, fax, or EHR integration. Regulatory credentials and specific certifications are not detailed on the website.

Cadwell Industries is a family-owned American manufacturer specializing in neurodiagnostic, neuromonitoring, and sleep diagnostic medical devices. Founded in 1979 and headquartered in Kennewick, Washington, the company employs approximately 260–281 people and maintains a strong commitment to in-house research and development. Cadwell's product portfolio includes the Sierra EMG/NCS/EP/Ultrasound systems for electromyography, nerve conduction studies, and evoked potentials; Arc EEG systems for electroencephalography and epilepsy monitoring; Cascade IONM equipment for intraoperative neurophysiological monitoring; and ApneaTrak HSAT and PSG systems for sleep diagnostics. The company also manufactures a comprehensive range of electrodes, consumables, supplies, and accessories for neurology applications. Cadwell serves hospitals, clinics, and home-care settings with global distribution, supported by dedicated customer service, online training resources, and educational workshops.

PranaQ is a medical device company specializing in home sleep apnea testing (HSAT) and monitoring solutions. The company's primary product, TipTraQ, is an FDA-cleared fingertip-based home sleep apnea diagnostic system that eliminates traditional testing burdens—no belts, nasal cannulas, wires, or adhesives. TipTraQ provides comprehensive sleep architecture analysis with AHI severity cutoffs compliant with both AASM 1A and 1B rules. The system delivers automated data upload, instant cloud-based result access, and remote patient management capabilities, designed to help clinicians expand HSAT services, reduce in-lab testing backlogs, and scale telehealth practices. Validation studies, including a Duke University Hospital clinical trial (NCT06351878) and peer-reviewed publication in SLEEP journal (Chen et al., 2025), demonstrate high accuracy in apnea event detection and timing analysis using deep learning AI. The platform is trusted by sleep medicine specialists, pulmonologists, and dental sleep medicine practitioners across the United States for both sleep apnea screening and oral appliance titration monitoring. PranaQ maintains offices in New York and Taipei, Taiwan.